CIK 0001501796 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Aura Biosciences, Inc.
Sign in to watch- Ticker
- AURA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 320271970
- Phone
- (617)500-8864
- Business address
- 80 GUEST STREET, BOSTON, MA, 02135
- 4 Grant or award See Remarks acquired 62,339 shares (grant or award)
- 4 Grant or award See Remarks acquired 71,245 shares (grant or award)
- 4 Grant or award See Remarks acquired 166,000 shares (grant or award)
- 4 Grant or award Chief Technology Officer acquired 62,339 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 89,056 shares (grant or award)
- 4 Grant or award Senior Vice President, Finance acquired 44,528 shares (grant or award)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale See Remarks sold 12,079 shares at $5.05 ($60,999)
- 4 Open-market sale Chief Technology Officer sold 15,890 shares at $5.05 ($80,245)
- 4 Open-market sale Chief Medical Officer sold 20,401 shares at $5.06 ($103,229)
- 4 Open-market sale Senior Vice President, Finance sold 8,549 shares at $5.06 ($43,258)
- 4 Open-market sale See Remarks sold 47,648 shares at $5.06 ($241,099)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
Page 4 of 20 · 383 filings